Institutional investors hold a majority ownership of JNJ through the 69.28% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARROWSTREET CAPITAL LP Bought 2.7 Million shares of Johnson & Johnson
THE VANGUARD GROUP, INC. Bought 2.0 Million shares of Johnson & Johnson
SANDERS CAPITAL LLC Bought 1.9 Million shares of Johnson & Johnson